Blueprint Medicines Reports Fourth Quarter and Full Year 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Blueprint Medicines Reports Fourth Quarter and Full Year 2015 Financial Results

Blueprint Medicines (BPMC) Misses Q4 EPS by 5c

March 11, 2016 8:10 AM EST

Blueprint Medicines (NASDAQ: BPMC) reported Q4 EPS of ($0.58), $0.05 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $4.64 million versus the consensus estimate of $2.85 million.

As of December 31, 2015, cash and cash equivalents were $162.7 million, as compared to $47.2 million as of... More